SMH
DOVA

Sanders Morris Harris’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Sanders Morris Harris’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-521,887
Closed -$7.36M – 295
2019
Q2 		$7.36M Buy
521,887
+239,972
+85% +$2.28M 1.91% 9
2019
Q1 		$2.51M Buy
+281,915
New +$2.29M 1.22% 18

Other funds holding DOVA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Morris Harris's DOVA Position: Q3 2019 in Review

Sanders Morris Harris sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q3 2019, closing a stake of 521,887 shares — an estimated $7.36M sold.

Sanders Morris Harris first reported a position in DOVA in Q1 2019 and held it in 2 quarters. The position peaked at $7.36M in Q2 2019. 72 funds tracked by Wall St. Rank hold DOVA as of Q3 2019.

  • Sanders Morris Harris reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Sanders Morris Harris sold 521,887 Dova Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $7.36M.
  • Sanders Morris Harris first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Sanders Morris Harris's Dova Pharmaceuticals, Inc. Common Stock position peaked at $7.36M in Q2 2019.
  • 72 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Sanders Morris Harris's 13F filing for Q3 2019, filed 14 Nov 2019.